Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comorbid neuropathological diagnoses in early versus late-onset Alzheimer’s disease
Salvatore Spina, Renaud La Joie, Cathrine Petersen, et al.
Brain (2021) Vol. 144, Iss. 7, pp. 2186-2198
Open Access | Times Cited: 176

Showing 1-25 of 176 citing articles:

Tauopathies: new perspectives and challenges
Yi Zhang, Kaimin Wu, Yang Liu, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 187
TDP-43 Pathology in Alzheimer’s Disease
Axel Meneses, Shunsuke Koga, Justin O’Leary, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 182
Advances and controversies in frontotemporal dementia: diagnosis, biomarkers, and therapeutic considerations
Bradley F. Boeve, Adam L. Boxer, Fiona Kumfor, et al.
The Lancet Neurology (2022) Vol. 21, Iss. 3, pp. 258-272
Open Access | Times Cited: 138
Clinical effects of Lewy body pathology in cognitively impaired individuals
Corinne Quadalti, Sebastian Palmqvist, Sara Hall, et al.
Nature Medicine (2023) Vol. 29, Iss. 8, pp. 1964-1970
Open Access | Times Cited: 77
Pathological combinations in neurodegenerative disease are heterogeneous and disease-associated
John Robinson, Sharon X. Xie, Daniel R. Baer, et al.
Brain (2023) Vol. 146, Iss. 6, pp. 2557-2569
Open Access | Times Cited: 67
Is Alzheimer disease a disease?
Amos D. Korczyn, Lea T. Grinberg
Nature Reviews Neurology (2024) Vol. 20, Iss. 4, pp. 245-251
Closed Access | Times Cited: 67
Alzheimer Disease as a Clinical-Biological Construct—An International Working Group Recommendation
Bruno Dubois, Nicolas Villain, Lon S. Schneider, et al.
JAMA Neurology (2024)
Closed Access | Times Cited: 66
Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysis
Marianne Chapleau, Renaud La Joie, Keir Yong, et al.
The Lancet Neurology (2024) Vol. 23, Iss. 2, pp. 168-177
Open Access | Times Cited: 29
NLRP3 inflammasome signalling in Alzheimer's disease
Róisín M. McManus, Eicke Latz
Neuropharmacology (2024) Vol. 252, pp. 109941-109941
Open Access | Times Cited: 27
A cross‐sectional study of α‐synuclein seed amplification assay in Alzheimer's disease neuroimaging initiative: Prevalence and associations with Alzheimer's disease biomarkers and cognitive function
Duygu Tosun, Zachary Hausle, Hirotaka Iwaki, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 8, pp. 5114-5131
Open Access | Times Cited: 20
Distinct tau and alpha-synuclein molecular signatures in Alzheimer’s disease with and without Lewy bodies and Parkinson’s disease with dementia
Bram van der Gaag, Natasja A. C. Deshayes, John J. P. Brevé, et al.
Acta Neuropathologica (2024) Vol. 147, Iss. 1
Open Access | Times Cited: 19
Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup
Gil D. Rabinovici, D. S. Knopman, Javier Arbizu, et al.
Alzheimer s & Dementia (2025)
Open Access | Times Cited: 12
Amyloid-β and heart failure in Alzheimer’s disease: the new vistas
Hayder M. Al‐kuraishy, Ghassan M. Sulaiman, Hamdoon A. Mohammed, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access | Times Cited: 4
Updated Appropriate Use Criteria for Amyloid and Tau PET: A Report from the Alzheimer’s Association and Society for Nuclear Medicine and Molecular Imaging Workgroup
Gil D. Rabinovici, D. S. Knopman, Javier Arbizu, et al.
Journal of Nuclear Medicine (2025), pp. jnumed.124.268756-jnumed.124.268756
Closed Access | Times Cited: 2
Locus coeruleus integrity is related to tau burden and memory loss in autosomal-dominant Alzheimer's disease
Martin J. Dahl, Mara Mather, Markus Werkle‐Bergner, et al.
Neurobiology of Aging (2021) Vol. 112, pp. 39-54
Open Access | Times Cited: 91
Recent update on the heterogeneity of the Alzheimer’s disease spectrum
K. A. Jellinger
Journal of Neural Transmission (2021) Vol. 129, Iss. 1, pp. 1-24
Closed Access | Times Cited: 87
Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer’s disease
Amelia Strom, Leonardo Iaccarino, Lauren Edwards, et al.
Brain (2021) Vol. 145, Iss. 2, pp. 713-728
Open Access | Times Cited: 70
The informed road map to prevention of Alzheimer Disease: A call to arms
Eric McDade, Jorge J. Llibre‐Guerra, David M. Holtzman, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 65
Current Concepts of Mixed Pathologies in Neurodegenerative Diseases
Shelley L. Forrest, Gábor G. Kovács
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques (2022) Vol. 50, Iss. 3, pp. 329-345
Open Access | Times Cited: 58
Amyloid, tau and metabolic PET correlates of cognition in early and late-onset Alzheimer’s disease
Jeremy A. Tanner, Leonardo Iaccarino, Lauren Edwards, et al.
Brain (2022) Vol. 145, Iss. 12, pp. 4489-4505
Open Access | Times Cited: 51
Sex-specific effects of microglial activation on Alzheimer’s disease proteinopathy in older adults
Kaitlin B. Casaletto, Emma Nichols, Vahan Aslanyan, et al.
Brain (2022) Vol. 145, Iss. 10, pp. 3536-3545
Open Access | Times Cited: 42
Amyloid and tau‐PET in early‐onset AD: Baseline data from the Longitudinal Early‐onset Alzheimer's Disease Study (LEADS)
Hanna Cho, Nidhi S. Mundada, Liana G. Apostolova, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. S9
Open Access | Times Cited: 32
The complex pathway between amyloid β and cognition: implications for therapy
William J. Jagust, Charlotte E. Teunissen, Charles DeCarli
The Lancet Neurology (2023) Vol. 22, Iss. 9, pp. 847-857
Open Access | Times Cited: 31
Advanced Overview of Biomarkers and Techniques for Early Diagnosis of Alzheimer’s Disease
Shital Rani, Sudhrita Basu Dhar, Akhil Khajuria, et al.
Cellular and Molecular Neurobiology (2023) Vol. 43, Iss. 6, pp. 2491-2523
Closed Access | Times Cited: 23
Individuals with Alzheimer's disease and low tau burden: Characteristics and implications
Susan Landau, JiaQie Lee, Alice Murphy, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 3, pp. 2113-2127
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top